Skip to main content
Home U.S.- CHINA | ECONOMIC and SECURITY REVIEW COMMISSION

U.S.-China Economic AND Security Review Commission

  • About Us
    hearings navigation
    About the Commission

    The U.S.-China Economic and Security Review Commission is a legislative branch commission created by the United States Congress in October 2000 with the legislative mandate to monitor, investigate, and submit to Congress an annual report on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China, and to provide recommendations, where appropriate, to Congress for legislative and administrative action.

    About the Commission
    • Charter
    • Commission Members
    • Commission Staff
    • Job Opportunities
    • Contact Us
  • Annual Reports
  • Recommendations
  • Hearings
  • Research
    research navigation menu drop down
    Research

    The U.S.-China Economic and Security Review Commission is chartered to monitor, investigate, and report to Congress on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China. The Commission meets its research mission by submitting to Congress an Annual Report, as well as by conducting staff-led reports, contracted research, and more.

    View All Research
    • RESEARCH BY TOPIC
      Censorship and Control RESEARCH BY TOPIC
    • China’s Economy and Resources
    • Compliance with International Rules and Norms
    • Finance and Investment
    • Global Relations and Influence
    • Hong Kong
    • Product Safety
    • Science and Technology
    • Security and Defense
    • Taiwan
    • Trade and Supply Chains
    • FEATURED RESEARCH
      Chinese Companies Listed on Major U.S. Stock Exchanges FEATURED RESEARCH
    • PRC in International Organizations
    • China-Ukraine Timeline

Search

Fentanyl: China’s Deadly Export to the United States

02/01/2017
Body

Mass quantities of fentanyl, a low-cost and highly potent synthetic drug, are being produced in China and brought illegally to the United States, contributing to a growing U.S. opioid crisis. The rise of fentanyl in the United States can be traced back to China’s large chemical and pharmaceutical industries, which manufacture vast quantities of the drug and its analogues to export to the western hemisphere with little regulatory oversight. This report examines how China’s illicit chemical production and inefficient U.S. and international counternarcotic efforts have contributed to dramatic increases in fentanyl-related deaths in the United States.

Tags
Product Safety
Fentanyl: China’s Deadly Export to the United States1 MB

Subscribe To Our Mailing List

CAPTCHA

Related Content

04/14/2023 • Research

Shein, Temu, and Chinese e-Commerce: Data Risks, Sourcing…

This Issue Brief details the challenges posed by Chinese “fast fashion” platforms, including… Read More
05/16/2019 • Research

China’s African Swine Fever Outbreak: Implications for U.S…

In 2018, China reported several cases of African swine fever, or ASF, a highly contagious disease… Read More
11/26/2018 • Research

Fentanyl Flows from China: An Update since 2017

This issue brief provides an update to the Commission's February 2017 report on fentanyl flows… Read More
08/08/2017 • Research

U.S. Exposure to Forced Labor Exports from China

China maintains a network of prison labor facilities that use forced labor to produce goods… Read More

U.S.-CHINA

U.S.-China Economic and
Security Review Commission

444 North Capitol Street NW, Suite 602
Washington, DC 20001

202-624-1407linkedintwitter

Footer menu

  • Contact Us
  • All Announcements
  • Privacy
  • Accessibility